Efficacy of Immediate Switching from Bicalutamide to Flutamide as Second-Line Combined Androgen Blockade

We determined whether prostate specific antigen (PSA) would decrease with immediate antiandrogen switching from bicalutamide (BCL) to flutamide (FLT) in patients receiving combined androgen blockade for advanced prostate cancer. From 2002 to 2006, 20 patients who showed PSA failure after first-line...

Descripción completa

Detalles Bibliográficos
Autores principales: Yokomizo, Yumiko, Kawahara, Takashi, Miyoshi, Yasuhide, Otani, Masako, Yamanaka, Shoji, Teranishi, Jun-ichi, Noguchi, Kazumi, Yao, Masahiro, Uemura, Hiroji
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi Publishing Corporation 2016
Materias:
Clinical Study
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4963562/
https://www.ncbi.nlm.nih.gov/pubmed/27493956
http://dx.doi.org/10.1155/2016/4083183

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4963562/
https://www.ncbi.nlm.nih.gov/pubmed/27493956
http://dx.doi.org/10.1155/2016/4083183

Ejemplares similares